Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natasha E Fullerton

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nuclear Medicine and Biology|October 26, 2005
Gene manipulation to enhance MIBG-targeted radionuclide therapyRobert J Mairs, Natasha E Fullerton, Emilio Cosimo, et al.
Practical Neurology|November 30, 2022
Headache with ataxic hemiparesisSacha E Gandhi, Natasha E Fullerton, Jagdish Ramachandran Nair, et al.
Dose-Response : a Publication of International Hormesis Society|July 24, 2008
Targeted radiotherapy: microgray doses and the bystander effectRobert J Mairs, Natasha E Fullerton, Michael R Zalutsky, et al.
Practical Neurology|June 16, 2023
Alcohol and the central nervous systemMaytal Wolfe, Arun Menon, Maria Oto, et al.
European Stroke Journal|January 30, 2026
Are lacunar infarcts associated with a "susceptibility vessel sign"? A 7-tesla magnetic resonance imaging studySam J Neilson, Natasha E Fullerton, Sin Yee Foo, et al.
Acta Neurochirurgica|January 10, 2023
Two cases of SMA syndrome after neurosurgical injury to the frontal aslant tractKevin Agyemang, Anna Rose, Mustafa El Sheikh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 3, 2006
Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclidesMarie Boyd, Susan C Ross, Jennifer Dorrens, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 22, 2006
Comparison of radiohaloanalogues of meta-iodobenzylguanidine (MIBG) for a combined gene- and targeted radiotherapy approach to bladder carcinomaNatasha E Fullerton, Marie Boyd, Susan C Ross, et al.
European Urology|January 22, 2005
Application of targeted radiotherapy/gene therapy to bladder cancer cell linesNatasha E Fullerton, Robert J Mairs, David Kirk, et al.
Practical Neurology|August 11, 2023
Leigh syndrome: an adult presentation of a paediatric diseaseTaylor Watson-Fargie, Victoria Marshall, Natasha E Fullerton, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nuclear Medicine and Biology|October 26, 2005
Gene manipulation to enhance MIBG-targeted radionuclide therapyRobert J Mairs, Natasha E Fullerton, Emilio Cosimo, et al.
Practical Neurology|November 30, 2022
Headache with ataxic hemiparesisSacha E Gandhi, Natasha E Fullerton, Jagdish Ramachandran Nair, et al.
Dose-Response : a Publication of International Hormesis Society|July 24, 2008
Targeted radiotherapy: microgray doses and the bystander effectRobert J Mairs, Natasha E Fullerton, Michael R Zalutsky, et al.
Practical Neurology|June 16, 2023
Alcohol and the central nervous systemMaytal Wolfe, Arun Menon, Maria Oto, et al.
European Stroke Journal|January 30, 2026
Are lacunar infarcts associated with a "susceptibility vessel sign"? A 7-tesla magnetic resonance imaging studySam J Neilson, Natasha E Fullerton, Sin Yee Foo, et al.
Acta Neurochirurgica|January 10, 2023
Two cases of SMA syndrome after neurosurgical injury to the frontal aslant tractKevin Agyemang, Anna Rose, Mustafa El Sheikh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 3, 2006
Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclidesMarie Boyd, Susan C Ross, Jennifer Dorrens, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 22, 2006
Comparison of radiohaloanalogues of meta-iodobenzylguanidine (MIBG) for a combined gene- and targeted radiotherapy approach to bladder carcinomaNatasha E Fullerton, Marie Boyd, Susan C Ross, et al.
European Urology|January 22, 2005
Application of targeted radiotherapy/gene therapy to bladder cancer cell linesNatasha E Fullerton, Robert J Mairs, David Kirk, et al.
Practical Neurology|August 11, 2023
Leigh syndrome: an adult presentation of a paediatric diseaseTaylor Watson-Fargie, Victoria Marshall, Natasha E Fullerton, et al.
Pageof 2